LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the company will be presenting at the 9th Annual MASS Opportunities Investment Conference on Thursday, November 8, 2007 at 10:30 AM (ET) at the Hilton Logan Airport, Boston.
